Geref (sermorelin acetate for injection)
Company: Serono LaboratoriesApproval Status: Approved October 1997
Treatment for: pediatric growth disorders
Areas: Diabetes / Endocrinology; Pediatrics
General Information
Serono Laboratories announced that Geref (sermorelin acetate for injection), its growth hormone releasing hormone, has received marketing clearance from the U.S. Food and Drug Administration. (FDA). Geref is indicated for growth hormone deficiency in children with growth failure and offers a new alternative of treatment.
Geref Drug Information
The Geref drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
